期刊文献+

女性膀胱过度活动症的临床研究(附218例报告) 被引量:13

Women overactive bladder clinical analysis of 218 cases.
下载PDF
导出
摘要 目的探讨女性膀胱过度活动症(OAB)的尿流率(UFR)临床特征,为临床治疗女性下尿路功能障碍提供有效的方法 ,提高女性OAB的诊疗水平。方法将218例女性OAB门诊患者分成两组。实验组:膀胱训练、CRS2280E深部热疗+经阴道行尿道微波治疗、普鲁本辛15mg 2次/d、艾司唑伦1mg h.s;对照组:宁泌泰胶囊4g 3次/d。结果女性OAB患者经物理治疗同时给予抑制逼尿肌收缩药物的治疗较单纯中药治疗有显著疗效。结论女性OAB的有效治疗对恢复下尿路功能,预防女性尿失禁有积极意义。 Objective To investigate women with overactive bladder(OAB)the urinary flow rate(UFR)characteristics curves for the advancement of women with OAB diagnosis and treatment of.Methods 218 cases of OAB female outpatients were divided into two groups.Experimental group:bladder traning,CRS2280E deep hyperthermia,transurethral urmicrowave Transvaginal line treatment.Prunelli the symplectic 15mg Bid,Estazolam 1mg h.s;control group:Ningmitai Capsule 4g tid.Results Patients with OAB at the same time give physical therapy by inhibiting detrusor control contraction machine than a simple drug treatment of Chinese medicine to cure a significant effect.Conclusion The female OAB effective treatment for restoring lower urinary tract function,the prevention of urinary incontinence in women has a positive meaning.
出处 《四川医学》 CAS 2010年第9期1305-1306,共2页 Sichuan Medical Journal
关键词 膀胱过度活动症 尿流率 膀胱训练 物理治疗 overactive bladder urinary flow rate bladder training:physical treatment
  • 相关文献

参考文献5

二级参考文献30

  • 1Milsom I,Abrams P,Cardozo L,et al.How widespread are the symptoms of an overactive bladder and how are they managed?A population-based prevalence study.Br J Urol Int,2001,87:760-766.
  • 2Stewart WF,Van Rooyen JB,Cundiff GW,et al.Prevalence and burden of overactive bladder in the United States.World J Urol,2003,9,20:327-336.
  • 3Moorthy P,Lapitan MC,Quek PL,et al.Prevalence of overactive bladder in Asian men:an epidemiological survey.BJU Int,2004,93:528-531.
  • 4Burgio KL.Influence of behavior modification on overactive bladder. Urology,2002,60(5 Suppl 1):72-76.
  • 5Burgio KL,Locher JL,Goode PS.Combined behavioral and drug therapy for urge incontinence in older women.J Am Geriatr Soc,2000,48:370-374.
  • 6Brady CM,Apostolidis AN,Harper M,et al.Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.BJU Int,2004,93:770-776.
  • 7Mattiasson A,Blaakaer J,Hoye K,et al.Tolterodine Scandinavian Study Group.Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder.BJU Int,2003,91:54-60.
  • 8Garat Barredo JM,Caffaratti Sfulcini J,de la Pena E.Treatment of bladder instability(non-neurogenic hyperactive bladder) in children,with tolterodine.Actas Urol Esp,2004,28:122-128.
  • 9Pak RW,Petrou SP,Staskin DR.Trospium chloride:a quaternary amine with unique pharmacologic properties.Curr Urol Rep,2003,4:436-440.
  • 10Zinner N,Gittelman M,Harris R,et al.Trospium Study Group.Trospium chloride improves overactive bladder symptoms:a multicenter phase III trial.J Uro,2004,171(6 Pt 1):2311-2315.

共引文献1590

同被引文献99

引证文献13

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部